A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,291,618 shares of MGTX stock, worth $22.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,291,618
Previous 5,291,618 -0.0%
Holding current value
$22.3 Million
Previous $37.1 Million 13.53%
% of portfolio
0.06%
Previous 0.08%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$3.6 - $7.15 $2.23 Million - $4.44 Million
620,601 Added 13.29%
5,291,618 $37.1 Million
Q2 2023

Aug 14, 2023

BUY
$5.19 - $8.07 $8.12 Million - $12.6 Million
1,565,217 Added 50.4%
4,671,017 $31.4 Million
Q2 2022

Aug 15, 2022

BUY
$6.8 - $14.23 $908,786 - $1.9 Million
133,645 Added 4.5%
3,105,800 $23.5 Million
Q1 2022

May 16, 2022

BUY
$13.42 - $23.38 $1.46 Million - $2.55 Million
109,101 Added 3.81%
2,972,155 $41.2 Million
Q4 2021

Feb 14, 2022

BUY
$12.78 - $23.74 $9.43 Million - $17.5 Million
738,054 Added 34.73%
2,863,054 $68 Million
Q3 2021

Nov 15, 2021

SELL
$11.73 - $16.08 $879,750 - $1.21 Million
-75,000 Reduced 3.41%
2,125,000 $28 Million
Q1 2021

May 17, 2021

BUY
$13.84 - $17.8 $3.46 Million - $4.45 Million
250,000 Added 12.82%
2,200,000 $31.7 Million
Q4 2020

Feb 16, 2021

BUY
$12.4 - $17.6 $18.6 Million - $26.4 Million
1,500,000 Added 333.33%
1,950,000 $29.5 Million
Q3 2020

Nov 16, 2020

SELL
$11.59 - $14.93 $289,750 - $373,250
-25,000 Reduced 5.26%
450,000 $5.96 Million
Q3 2019

Nov 14, 2019

BUY
$15.84 - $30.01 $4.75 Million - $9 Million
300,000 Added 171.43%
475,000 $7.58 Million
Q1 2019

May 15, 2019

BUY
$9.2 - $21.21 $1.61 Million - $3.71 Million
175,000 New
175,000 $3.02 Million

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $189M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.